DELTA-9-TETRAHYDROCANNABINOL IN CANCER-CHEMOTHERAPY - RESEARCH PROBLEMS AND ISSUES

被引：52

作者：

CAREY, MP

BURISH, TG

BRENNER, DE

机构：

[1] VANDERBILT UNIV, DEPT PSYCHOL, NASHVILLE, TN 37240 USA

[2] VANDERBILT UNIV, MED CTR, SCH MED, DEPT MED, NASHVILLE, TN 37232 USA

来源：

ANNALS OF INTERNAL MEDICINE | 1983年 / 99卷 / 01期

关键词：

D O I：

10.7326/0003-4819-99-1-106

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：106 / 114

页数：9

共 51 条

[1]

ANDRYSIAK T, 1979, AM J NURS, V79, P1396

[2]

BENOWITZ NL, 1977, CLIN PHARMACOL THER, V22, P259

[3]

BORISON HL, 1953, PHARMACOL REV, V5, P193

[4]

BURISH T G, 1981, Journal of Behavioral Medicine, V4, P65, DOI 10.1007/BF00844848

[5] DELTA-9-TETRAHYDROCANNABINOL AS AN ANTI-EMETIC IN CANCER-PATIENTS RECEIVING HIGH-DOSE METHOTREXATE - PROSPECTIVE, RANDOMIZED EVALUATION [J].

CHANG, AE ;

SHILING, DJ ;

STILLMAN, RC ;

GOLDBERG, NH ;

SEIPP, CA ;

BAROFSKY, I ;

SIMON, RM ;

ROSENBERG, SA .

ANNALS OF INTERNAL MEDICINE, 1979, 91 (06) :819-824

[6]

CHANG AE, 1981, CANCER, V47, P1746

[7]

Chassan J. B, 1979, RES DESIGN CLIN PSYC

[8]

COLLS BM, 1980, NEW ZEAL MED J, V91, P449

[9]

COTANCH PH, 1983, CANCER NURS

[10]

DUGAN WM, 1981, NEW ENGL J MED, V305, P769

← 1 2 3 4 5 6 →